These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6992679)

  • 1. Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma.
    Sweet DL; Golomb HM; Ultmann JE; Miller JB; Stein RS; Lester EP; Mintz U; Bitran JD; Streuli RA; Daly K; Roth NO
    Ann Intern Med; 1980 Jun; 92(6):785-90. PubMed ID: 6992679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
    Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution.
    Gaynor ER; Ultmann JE; Golomb HM; Sweet DL
    J Clin Oncol; 1985 Dec; 3(12):1596-604. PubMed ID: 3877790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the Lukes and Collins classification in patient treated with COMLA.
    Sweet DL; Collins RD; Stein RS; Ultmann JE
    Cancer Treat Rep; 1982 May; 66(5):1107-11. PubMed ID: 7044531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMLA chemotherapy for lymphoma.
    Raich PC
    Ann Intern Med; 1980 Sep; 93(3):509-10. PubMed ID: 7001970
    [No Abstract]   [Full Text] [Related]  

  • 7. A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma.
    Todd M; Cadman E; Spiro P; Bertino J; Farber L; Waldron J; Fischer D
    J Clin Oncol; 1984 Sep; 2(9):986-93. PubMed ID: 6206207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites.
    Cadman E; Farber L; Berd D; Bertino J
    Cancer Treat Rep; 1977 Sep; 61(6):1109-16. PubMed ID: 332346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimen.
    Baer MR; Stein RS; Greer JP; Wolff SN; Hainsworth JD; Flexner JM
    Cancer Treat Rep; 1986 Jun; 70(6):785-7. PubMed ID: 3488125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle agents and cyclophosphamide in the treatment of diffuse histiocytic lymphoma.
    Gomez GA; Stutzman L
    Eur J Cancer (1965); 1978 Oct; 14(10):1051-5. PubMed ID: 361413
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy.
    Berd D; Cornog J; DeConti RC; Levitt M; Bertino JR
    Cancer; 1975 Apr; 35(4):1050-4. PubMed ID: 1090359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
    Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
    Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).
    Skarin AT; Canellos GP; Rosenthal DS; Case DC; MacIntyre JM; Pinkus GS; Moloney WC; Frei E
    J Clin Oncol; 1983 Feb; 1(2):91-8. PubMed ID: 6199472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen.
    Laurence J; Coleman M; Allen SL; Silver RT; Pasmantier M
    Ann Intern Med; 1982 Aug; 97(2):190-5. PubMed ID: 6179448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
    Durant JR; Loeb V; Dorfman R; Chan YK
    Cancer; 1975 Dec; 36(6):1936-44. PubMed ID: 1106833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of malignant lymphoma].
    Horikoshi N; Ogawa M
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1903-10. PubMed ID: 6985187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival of patients with localized diffuse histiocytic lymphoma.
    Vokes EE; Ultmann JE; Golomb HM; Gaynor ER; Ferguson DJ; Griem ML; Oleske D
    J Clin Oncol; 1985 Oct; 3(10):1309-17. PubMed ID: 3900300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of histiocytic lymphoma.
    Sweet DL; Golomb HM
    Semin Oncol; 1980 Sep; 7(3):302-9. PubMed ID: 6774422
    [No Abstract]   [Full Text] [Related]  

  • 19. Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) without maintenance therapy.
    Armitage JO; Corder MP; Leimert JT; Dick FR; Elliot TE
    Cancer Treat Rep; 1980; 64(4-5):649-54. PubMed ID: 7000347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP.
    Olopade OI; Larson RA; Mick R; Watson SM; Hoffman PC; Ultmann JE; Golomb HM
    Leukemia; 1990 Feb; 4(2):127-31. PubMed ID: 1689439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.